Bal Krishan Sharma1, Duaa Mureb1, Sumit Murab2, Leah Rosenfeldt1, Brenton Francisco1, Rachel Cantrell1, Rebekah Karns3, Lindsey Romick-Rosendale4, Miki Watanabe-Chailland4, Jacob Mast1, Matthew J Flick5, Patrick W Whitlock2, Joseph S Palumbo1. 1. Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, USA. 2. Division of Orthopaedics Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 3. Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 4. Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 5. Department of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, and the UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Abstract
BACKGROUND: We previously showed that fibrinogen is a major determinant of the growth of a murine model of colorectal cancer (CRC). OBJECTIVE: Our aim was to define the mechanisms coupling fibrin(ogen) to CRC growth. RESULTS: CRC tumors transplanted into the dorsal subcutis of Fib- mice were less proliferative and demonstrated increased senescence relative to those grown in Fib+ mice. RNA-seq analyses of Fib+ and Fib- tumors revealed 213 differentially regulated genes. One gene highly upregulated in tumors from Fib- mice was stratifin, encoding 14-3-3σ, a master regulator of proliferation/senescence. In a separate cohort, we observed significantly increased protein levels of 14-3-3σ and its upstream and downstream targets (i.e., p53 and p21) in tumors from Fib- mice. In vitro analyses demonstrated increased tumor cell proliferation in a fibrin printed three-dimensional environment compared with controls, suggesting that fibrin(ogen) in the tumor microenvironment promotes tumor growth in this context via a tumor cell intrinsic mechanism. In vivo analyses showed diminished activation of focal adhesion kinase (FAK), a key negative regulator of p53, in Fib- tumors. Furthermore, nuclear magnetic resonance-based metabolomics demonstrated significantly reduced metabolic activity in tumors from Fib- relative to Fib+ mice. Together, these findings suggest that fibrin(ogen)-mediated engagement of colon cancer cells activates FAK, which inhibits p53 and its downstream targets including 14-3-3σ and p21, thereby promoting cellular proliferation and preventing senescence. CONCLUSIONS: These studies suggest that fibrin(ogen) is an important component of the colon cancer microenvironment and may be exploited as a potential therapeutic target.
BACKGROUND: We previously showed that fibrinogen is a major determinant of the growth of a murine model of colorectal cancer (CRC). OBJECTIVE: Our aim was to define the mechanisms coupling fibrin(ogen) to CRC growth. RESULTS: CRC tumors transplanted into the dorsal subcutis of Fib- mice were less proliferative and demonstrated increased senescence relative to those grown in Fib+ mice. RNA-seq analyses of Fib+ and Fib- tumors revealed 213 differentially regulated genes. One gene highly upregulated in tumors from Fib- mice was stratifin, encoding 14-3-3σ, a master regulator of proliferation/senescence. In a separate cohort, we observed significantly increased protein levels of 14-3-3σ and its upstream and downstream targets (i.e., p53 and p21) in tumors from Fib- mice. In vitro analyses demonstrated increased tumor cell proliferation in a fibrin printed three-dimensional environment compared with controls, suggesting that fibrin(ogen) in the tumor microenvironment promotes tumor growth in this context via a tumor cell intrinsic mechanism. In vivo analyses showed diminished activation of focal adhesion kinase (FAK), a key negative regulator of p53, in Fib- tumors. Furthermore, nuclear magnetic resonance-based metabolomics demonstrated significantly reduced metabolic activity in tumors from Fib- relative to Fib+ mice. Together, these findings suggest that fibrin(ogen)-mediated engagement of colon cancer cells activates FAK, which inhibits p53 and its downstream targets including 14-3-3σ and p21, thereby promoting cellular proliferation and preventing senescence. CONCLUSIONS: These studies suggest that fibrin(ogen) is an important component of the colon cancer microenvironment and may be exploited as a potential therapeutic target.
Authors: Tao Jiang; Jose G Munguia-Lopez; Kevin Gu; Maeva M Bavoux; Salvador Flores-Torres; Jacqueline Kort-Mascort; Joel Grant; Sanahan Vijayakumar; Antonio De Leon-Rodriguez; Allen J Ehrlicher; Joseph M Kinsella Journal: Biofabrication Date: 2019-12-31 Impact factor: 9.954
Authors: T T Suh; K Holmbäck; N J Jensen; C C Daugherty; K Small; D I Simon; S Potter; J L Degen Journal: Genes Dev Date: 1995-08-15 Impact factor: 11.361
Authors: Anna K Kopec; Nikita Joshi; Holly Cline-Fedewa; Anna V Wojcicki; Jessica L Ray; Bradley P Sullivan; John E Froehlich; Brendan F Johnson; Matthew J Flick; James P Luyendyk Journal: J Hepatol Date: 2016-12-10 Impact factor: 25.083
Authors: Joni M Prasad; Oleg V Gorkun; Harini Raghu; Sherry Thornton; Eric S Mullins; Joseph S Palumbo; Ya-Ping Ko; Magnus Höök; Tovo David; Shaun R Coughlin; Jay L Degen; Matthew J Flick Journal: Blood Date: 2015-07-30 Impact factor: 22.113
Authors: Gregory N Adams; Leah Rosenfeldt; Malinda Frederick; Whitney Miller; Dusty Waltz; Keith Kombrinck; Kathryn E McElhinney; Matthew J Flick; Brett P Monia; Alexey S Revenko; Joseph S Palumbo Journal: Cancer Res Date: 2015-08-03 Impact factor: 12.701
Authors: J S Palumbo; K A Barney; E A Blevins; M A Shaw; A Mishra; M J Flick; K W Kombrinck; K E Talmage; M Souri; A Ichinose; J L Degen Journal: J Thromb Haemost Date: 2008-02-25 Impact factor: 5.824